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Women’s perspectives on Human Papillomavirus self-sampling in the context of the UK 



































Background: Testing for Human Papillomavirus (HPV) is being incorporated into the cervical 
screening programme, with the probable future introduction of HPV as a primary test and a 
possibility of HPV self-sampling. In anticipation of this development, we sought to inform 
future policy and practice by identifying potential barriers to HPV self-sampling. 
Methods: A cross-sectional survey of 194 women aged 20-64 years was conducted. Logistic 
regression analysis was used to identify determinants of self-sampling intentions. A 
purposive sub-sample of 19 women who reported low self-sampling intentions were 
interviewed. Interviews were framework analysed.  
Results: Most survey participants (N=133, 69.3%) intended to HPV self-sample. Lower 
intention was associated with: lower self-efficacy (OR=24.96, p≤.001), lower education 
(OR=6.06, p≤.05), and lower perceived importance of HPV as a cause of cervical cancer 
(OR=2.33, p≤.05). Interviews revealed personal and system related barriers. Personal 
barriers included a lack of knowledge about HPV self-sampling, women’s low confidence in 
their ability to self-sample correctly and low confidence in the subsequent results. System-
related factors included a lack of confidence in the rationale for modifying the current 
cervical screening programme, and concerns about sample contamination and identity 
theft.   
Conclusions: Insights gained from this research can be used to guide further enquiry into 
the possibility of HPV self-sampling and to help inform future policy and practice. Personal 
and system related barriers including low confidence in the reasons for changing current 
cervical screening provision need to be addressed, should HPV self-sampling be 










Women’s perspectives on Human Papillomavirus self-sampling in the context 




Cervical cancer is the second most common cancer in women worldwide with 527,000 new 
cases annually [1]. In the UK, cervical cancer is the third most common gynaecological 
cancer after ovarian and uterine cancer [2] and the second most commonly diagnosed 
cancer in women aged under 45 years [3]. Cervical screening is routinely offered to all 
eligible women in the UK using cervical cytology by National Health Service (NHS) Cervical 
Screening programmes. Cervical screening is offered to women between the ages of 25-64 
years in England, Wales, Northern Ireland and Scotland. Women under 50 years of age are 
invited for screening every three years, whilst women over 50 years of age are invited for 
screening every five years. Cervical screening is free and offered by regional NHS Cervical 
Screening programmes. 
 
Over the past decade, cervical screening coverage has been steadily declining throughout 
the UK [4, 5]. Cervical screening uptake is below the NHS cervical screening target of 80% 
needed to ensure cost-effectiveness and to significantly reduce cervical cancer incidence [6]. 
Non-attenders are at higher risk of developing cervical cancer [7]. Younger age [8, 9], high 
deprivation [10] and being from an ethnic minority background [11] have been associated 
with poor uptake of cervical screening. Inconvenient appointment times [12], gender of the 
medical practitioner [13], embarrassment [14], lack of trust in health professionals [15], 
concerns about discomfort [16] and the inconvenience of having to make appointments [9, 
17] have been identified as barriers to cervical screening.  
 
The main aetiological agent in the development of cervical cancer is a sexually transmitted 
infection of a viral nature called Human Papillomavirus (HPV) [18]. HPV infections are 
common and most sexually active men and women will become infected with HPV at some 
point in their lives [19]. Although in most cases the infection will clear on its own [20], 
persistent high risk types of HPV (oncogenic) are associated with cancers of the cervix, 
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vulva, vagina, penis, anus and rectum. The high risk types of HPV 16 and 18 are known to 
account for 70% of all cervical cancer cases. The identification of high risk types of Human 
Papillomavirus (HPV) as a cause of cervical cancer has facilitated cervical screening using 
HPV DNA assays [21]. HPV testing has a higher sensitivity for high grade precancerous 
disease than cytology, and may extend screening intervals and  reduce the number of 
colposcopy examinations in women with borderline or low grade dyskaryosis on cervical 
cytology [22]. The evaluation of how to incorporate HPV testing into the cervical screening 
programme began in 2008 in England with the Sentinel Sites project.  The use of HPV testing 
in cervical cancer screening has gained momentum in the UK, most recently with the 
approval of primary HPV screening [23] and the UK National Screening Committee 
recommendation that HPV testing is incorporated as a primary screening tool [24] . 
 
Consequently, cervical screening programmes in the UK are changing to facilitate a new era 
of cervical screening. HPV testing as ‘test of cure’ following treatment and to triage women 
with borderline and low-grade dyskaryosis for high risk HPV, is currently being incorporated 
throughout the UK [25], although it is not yet used as a primary screening modality.  
Due to growing evidence of superior sensitivity and negative predictive value compared to 
cervical cytology [26] and recent recommendations [24], it seems that future cervical cancer 
screening in high resource settings such as the UK will evolve to include primary HPV testing. 
In fact, Australia has recently announced that HPV testing will replace cytology as the 
primary cervical screening modality from 2017 following extensive review (“Renewal”) [27]. 
However, implementation of primary HPV screening in the UK will require consideration of 
appropriate screening intervals, defining triage and management policies for HPV positive 
women, ensuring quality and adherence to revised policies, the new type of HPV screening 
test to be used and its acceptability to women.  
 
Self-sampling methods are increasingly advocated in tests for sexually transmitted infections 
[28]. HPV self-sampling allows a woman to collect a sample of her own cells at home for 
HPV DNA testing and could be used as a form of HPV testing in the U.K. cervical screening 
programme. A randomised controlled trial exploring HPV self-sampling as an alternative 
strategy for cervical screening in non-responder women found 99% of 96 returned HPV self-
samples to be adequate for analysis [29]. Low acceptability and uptake are major obstacles 
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to the successful implementation of any new screening programme [19] and must be 
considered during policy recommendations. Previous research conducted in the UK, 
Netherlands and Canada has identified benefits of HPV self-sampling including perceived 
convenience and reduced discomfort and embarrassment by avoiding gynaecological 
examinations [30-34]. In contrast, beliefs that HPV self-sampling might cause trauma, 
concerns about not doing the test properly, and a lack of trust in the accuracy of results 
have been identified as barriers [17, 35, 36]. Most research to date has focused on the views 
of women who are cervical screening non-attenders; however, their views may not reflect 
those of women who adhere to current cervical screening guidelines. Moreover, cultural 
and health care system differences between countries may influence screening attitudes 
and intentions, resulting in findings being less applicable to different populations. In the 
absence of current UK policy regarding primary HPV testing and HPV self-sampling, it is also 
important to understand the attitudes and likely behavioural responses of women who are 
engaged with the existing cervical screening programme.  
 
Self-efficacy— an individual’s belief in their capability to exercise control over challenging 
demands— is considered to be one of the most powerful predictors of health behaviour 
[37]. Self-efficacy has been shown to predict uptake of cervical screening [38] and is highly 
relevant to HPV self-sampling because women are expected to take a sample 
independently. Self-efficacy is part of the Health Belief Model (HBM) [27], which has proven 
relevance to preventative health behaviour, such as participation in screening and 
vaccination programmes [39]. The HBM proposes that intentions are determined by beliefs 
relating to susceptibility to and severity of HPV infection, perceived self-efficacy in being 
able to correctly carry out self-sampling, and the perceived barriers and benefits of self-
sampling compared to cervical smear tests.  
 
The present study used mixed methods to understand women’s attitudes and intentions 
regarding HPV self-sampling, and in particular the influence of self-efficacy on intentions to 
HPV self-sample. The overarching aim was to generate recommendations to inform future 







Participants and Recruitment 
Women aged 20-64 years who were resident in South East Wales and gave written informed 
consent were approached to take part in the study during 2012 – 2013. The main 
recruitment source was Cervical Screening Wales, with supplementary recruitment through 
primary care and sexual health clinics, local community groups and snowball sampling. 
Supplementary recruitment was needed to ensure that the target sample size was achieved 
and to help increase sample heterogeneity. It was calculated that a survey sample size of 
172 participants would achieve 90% power to detect an odds ratio of 2 for the effect of self-
efficacy on intention to self-sample. Survey respondents who indicated willingness to 
participate in a further interview were purposively sampled for a lower intention to HPV 
self-sample, based on their survey responses.  
 
Ethical Approval 
The study received approval from the South East Wales Local Research Ethics Committee C 
(REC: 11/WA/0213) and Public Health Wales Research and Development (REF: 
2012PHW0023). 
Procedure 
A mixed-methods design was adopted using a cross-sectional survey and semi-structured 
interviews, in which HPV self-sampling was presented as a hypothetical cervical screening 
method.  Women who were recruited through Cervical Screening Wales were sent an 
invitation leaflet and freepost envelope with their standard cervical screening invitation 
letter inviting them to express interest in the study. Women who were interested in 
participating were instructed to fill in their details on the reverse of the recruitment card 
and to return it using the supplied pre-paid envelope. Women who returned the completed 
recruitment card were then sent the full participant pack and survey. 
For the supplementary recruitment, women were approached to participate at the 
additional recruitment sites. Survey respondents were purposively sampled for lower 
intention to HPV self-sample and were invited to take part in a semi-structured interview 
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conducted in their homes or at a suitable alternative venue. All interviews were audio-
recorded with consent, anonymised and transcribed verbatim.  
 
MATERIALS 
Survey Measures: A theoretically based (HBM) survey was developed to measure women’s 
attitudes and intentions regarding HPV self-sampling, in order to examine the determinants 
of anticipated uptake. Content validity analysis with health research experts facilitated the 
development of the survey. The use of patient and public involvement (PPI) of women 
eligible for cervical screening through cognitive interviews, helped to ensure that the format 
of the survey was accessible, and that individual items were easily and correctly understood. 
Overall, the survey was well received by participants. Survey measures included HPV and 
cervical cancer knowledge, HPV self-sampling intention, self-efficacy in relation to HPV self-
sampling, perceived susceptibility to and severity of HPV infection/cervical cancer, and 
perceived benefits/barriers to HPV self-sampling. Cervical screening history and 
demographic variables were also included (see Supplementary material 1 for further 
details).  All HBM items were scored on 5-point Likert response scales. Reliable scales were 
identified through a principal components analysis of items relating to HBM a priori 
constructs. Five factors with eigenvalues >1.00 were extracted. As shown in Table 1, factors 
loaded in line with theoretical expectations. Loading strength and conceptual issues were 
considered when deciding which a priori item should be retained on each component.  The 
internal reliability of factor derived scales was variable. Intention to HPV self-sample (α= 
0.93), self-efficacy (α= 0.90) and benefits to cervical screening (α= 0.80) exhibited high 
internal reliability, whilst barriers to HPV self-sampling (α=0.58), benefits to HPV self-
sampling (α=0.55) and barriers to cervical screening (α=0.44) exhibited low internal 
reliability.  
 
TABLE 1 HERE 
 
Interviews: Interviews were conducted by DW using a semi-structured interview schedule 
(Supplementary material 2) and focused on understanding participant perceptions of 
primary HPV self-sampling, if it was incorporated into the cervical screening system. The 
interview schedule was theory-based and drew on the extended Health Belief Model 
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constructs and concepts identified as significantly associated with intention to self-sample 
during survey analysis. The interview schedule was divided into two sections which explored 
perceptions relating to (1) HPV self-sampling and HPV in general, and (2) experiences of 
cervical smear tests. Sampling continued until no new significant or relevant themes of 
interest to the study objectives were identified.  
 
ANALYSIS 
Survey data were analysed using SPSS for Windows version 20. Participants with missing 
data were excluded from analyses. Descriptive statistics were used to characterise the 
sample, followed by univariate analyses to examine preliminary associations between 
intention to self-sample, sociodemographic and HBM factors, HPV knowledge and past 
cervical screening history (chi square tests or independent t-tests as appropriate). Logistic 
regression was used to identify the strongest predictors of intention to self-sample, with a 
binary intention outcome measure entered as the dependent variable (higher intention 
versus lower intention to HPV self-sample). Due to non-normal distribution of the intention 
measure, a binary intention measure was created from participants’ Likert scale responses 
(1-5). Those who were classified as having a higher intention to HPV self-sample scored 4 or 
5 on all three intention items, whilst those who scored 3 or under on any of the three 
intention items were classified as having a lower intention to HPV self-sample (see 
Supplementary material 1 for details). Statistically significant variables identified during 
univariate analyses (p<0.05) were modelled to determine their effects on self-sampling 
intention.  
 
Interviews were analysed by DW using a Framework approach [40]. Following familiarisation 
with the data, a framework was developed based on a priori constructs (as identified in the 
survey and HBM) and new themes relevant to the research question emerging from the 
data as discussed among the research group. The framework was expanded and modified 
during the analysis and was used to filter and classify all data. Twenty five percent of 
transcripts were double coded by MD, with inter-rater agreement satisfactory at 85% 






Of the 11,961 women who received a recruitment leaflet with their cervical screening 
invitation/recall letter from Cervical Screening Wales, 840 returned an expression of interest 
in the study and were sent a study recruitment pack. One hundred and thirty seven of 840 
(16.31%) women who received a recruitment pack, completed the survey. A further 57 
women were recruited through GP surgeries, community groups and sexual health clinics to 
increase sample size and representation. The final survey sample therefore consisted of a 
total 194 participants, 137 (71%) of whom were recruited through Cervical Screening Wales 
and 57 (29%) from supplementary recruitment sources. Nineteen women who had 
consented to be contacted for an interview and who were classified by the survey as less 






Most survey participants were of white ethnicity, in the 31-49 year age group, highly 
educated and were home owners. The majority had attended a cervical screen within the 
last four years. Nearly half (43.0%) of participants had received an abnormal smear test 
result and approximately a quarter (18.2%) had received treatment for cervical 
abnormalities. A small proportion of women knew a family member/friend diagnosed with 
cervical cancer (13.5%) and some had known someone die of cervical cancer (5.7%). Table 2 
illustrates participant characteristics. The subset of interview participants was aged 
between 23 and 63 years. Most were from a white background (n=17) and educated to a 
degree level (n=10). Over half had received a previous abnormal cervical smear test result 
(n=12).  
 






Overall, most women (N=133, 69%) reported high intention to HPV self-sample. HPV 
knowledge was low: 31.4% of participants had not heard of HPV before participating in the 
study, 25% (N=41) believed that HPV could be transmitted by means other than sexual 
contact, 32.3% of women believed that HPV could be treated with medicines and 51.6% 
believed that HPV could not clear up on its own.  
 
Preliminary associations between independent variables and intention (Supplementary 
material 3 and 4) indicated that lower intention to self-sample was significantly associated 
with lower educational attainment (p<0.05), white ethnicity (p<0.01), lower self-efficacy 
(p≤0.001), fewer perceived benefits (p<0.002) and more perceived barriers (p<0.001) to HPV 
self-sampling, fewer perceived benefits of smear tests (p<0.028), low HPV knowledge 
(p<0.02), and the perception that HPV is not an important cause of cervical cancer (M4.14, 
S.D. 0.91, p<0.007). 
 
The regression model was significant [X2 (14, N=174) =98.120, p<0.001] indicating that it was 
able to distinguish between women who had a lower or higher intention to HPV self-sample. 
The model correctly classified 83.3% of cases and explained between 43.1% and 61.2% of 
variance in intention to self-sample. Self-efficacy in relation to HPV self-sampling had the 
strongest influence on intention (p<0.001, OR= 24.96, 95% CI 6.34-98). Higher educational 
level was also associated with higher intention to self-sample (p=0.016, OR=6.06, 95% CI 
1.40-26.14). Women with a lower intention perceived HPV as less important in causing 
cervical cancer (p=0.034, OR=2.33, 95% CI 1.07-5.07), perceived more barriers (p <0.001, 
OR=0.663, 95% CI 0.53-0.82) and fewer benefits to self-sampling (p=.012, OR=1.36, 95% CI 
1.07-1.74) and cervical smear tests (p=0.016, OR=1.43, 95% CI 1.07-1.91) than women with 
a higher intention to self-sample (Table 3).  
 




Qualitative analysis revealed the following key themes as influences on women’s lower 
intentions to primary HPV self-sample. A summary of identified barriers to HPV self-
sampling intentions is presented in Table 4.  
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HPV knowledge  
 
Most women did not know what caused cervical cancer. Some attributed cervical cancer to 
lifestyle factors, genetic factors or something that just happens. 
“I think it’s more a genetic thing and passed down” (P18) 
“lifestyle and your diet and um stress I guess, all sorts of things” (P17) 
Consequently, women had very little knowledge of HPV and reported embarrassment about 
their lack of knowledge. 
“I don’t know nothing at all about it” (P4)  
“I’m a bit embarrassed that I don’t know more about it (P11)”.    
Women also discussed sex education and stated that they had not been taught about HPV 
or its link with cervical cancer. Some women acknowledged that they had been regular 
cervical smear attenders from a young age, but that the role of HPV in cervical cancer was 
never explained to them. Consequently, women felt that more education about cervical 
cancer and HPV was needed. 
“basically my generation was never educated in anything like that, you know 
especially with school with sex education … so  I think for me I’m a missed 
generation to understand what it is fully” (P10) 
Understanding HPV self-sampling      
Women had a basic understanding of HPV self-sampling, which was attributed to the 
description of what HPV self-sampling would involve which was included in their participant 
information packs. However, women rationalised their understanding in the context of 
cervical smear tests and perceived similarities. Most women believed that the self-sampling 
kit would involve collection of material from the cervix and some also believed that a 
speculum might need to be used. Primarily, women were concerned that this would be 
difficult to perform. 
“my only concern would be am I putting it in far enough, because obviously 
when they do a smear test they open up your sort of cervix type thing and 
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then they take, it’s in quite deep to take the sample and it would be “am I 
inserting it high enough?” (P17) 
Barriers to self-sampling                                                                                                                              
Availability of a cervical smear was an important influence on intention to self-sample. 
Women stated that their intention would be highly influenced by the availability of an 
alternative, and often saw self-sampling as an inferior method of cervical screening 
compared to cervical smears. 
“if it was the only option that I had then I would do it… but if I had an option 
of having a smear test with the nurse, or doing it myself then I’d go with the 
nurse” (P1) 
Women’s preference for cervical smear tests appeared to be linked to their confidence in 
the current form of cervical screening, and concerns about losing access to professional 
expertise. 
“you know if you were to use, use the self-sampling would you still be able to 
go then to your GP”  (P3)  
The habitual nature of cervical screening behaviour influenced women’s intentions to self-
sample, with women who expressed a preference for the habitual behaviour reporting a 
lower intention. 
Women were also worried about sample contamination due to sampling at home, which 
they saw as a non-sterile environment. Women were concerned that they might not be able 
to carry out self-sampling properly due to a lack of practice and medical expertise. 
“my concern would be if a medical person had been doing this for all this 
time, would your sample be good enough?” (P9).  
Women reported a lack of confidence in self-sampling results by saying that they might have 
“missed something” (P2), and some referred to carrying out self-sampling incorrectly and 
receiving a false negative result as entering into a “life and death situation” (P1).                                                            
When discussing operational factors associated with HPV self-sampling, operational themes 
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emerged including women’s concerns that postal workers might be unwilling to handle kits 
and worry about identity theft, because self-sampling kits would contain DNA and personal 
details. 
“if I was a post lady I wouldn’t want to handle someone’s thing that’s been in 
places” (P4) 
One of the most recurrent and unprompted operational barriers was concern that the 
laboratory would not confirm receipt of the self-sampling kit, which affected women’s 
confidence in the set-up of a new screening process:  
“If there’s nothing about acknowledgment of samples…it would make me 
have entirely less confidence in the whole process” (P5).  
Finally, women felt that the imperative for self-sampling might be “politically motivated” 
and “rushed through” (P5) in order to cut costs for the NHS. Consequently, concerns were 
raised about withdrawal of service: “Are they taking away my rights to have a smear test?” 
(P13). Barriers identified from the initial framework included worry about the self-sampling 
kit getting lost or contaminated in the post. 
Facilitators to self-sampling                                                                                                                
Convenience, speed and the perception that self-sampling would be less embarrassing, 
uncomfortable and invasive than cervical smear testing were facilitators to self-sampling. 
Women had altruistic beliefs and reported that participating in self-sampling might release 
health practitioner appointments to others whose needs were more urgent. Some women 
also felt that self-sampling would be a more cost-effective form of screening and that saved 
funds could be distributed elsewhere 
“they can help someone who needs more crucial help than doing a sample” 
(P17).  
“it’s worthwhile because the funds would then go to… treating people with 











In the event that HPV self-sampling is incorporated into UK cervical screening programmes, 
research examining barriers and facilitators will be important to highlight potential 
problems with acceptability and uptake and to direct service recommendations. The present 
study identified the impact of personal and system-related barriers on women’s attitudes 
towards primary HPV self-sampling, and their intention to HPV self-sample.  As well as 
identifying barriers and benefits associated with HPV self-sampling, the study provided 
important insights into women’s perceptions regarding a potential change from a familiar 
and established healthcare system (cervical smear testing) to a new and different type of 
cervical screening system (HPV self-sampling). Public concerns about safety and 
acceptability should be addressed if primary HPV self-sampling is to become incorporated 
into the cervical screening programme.  
 
Reflecting previous research [42, 43], barriers to self-sampling included a lack of HPV 
knowledge and concerns about conducting self-sampling properly [33, 44]. Although 
concerns about performing self-sampling correctly have been identified in previous studies, 
the current survey was the first to quantify the strength of the relationship between self-
efficacy and intention to self-sample, and to identify key variables for subsequent in-depth 
exploration. This study highlighted the importance of self-efficacy in women’s intention to 
HPV self-sample and qualitative results provided further insight into how low self-efficacy 
affected women’s intentions. Women believed that they might fail to take the sample from 
the area at most risk within their vagina. Consequently, women were worried that this 
would lead to an incorrect negative result and that they would not get an opportunity for 
repeat screening until the next routine screening round. When explaining their lack of 
confidence in self-sampling results, women referred to a lack of personal expertise, lack of 
practice and a lack of knowledge. Consequently, some women perceived the introduction of 
primary HPV self-sampling as service withdrawal and stated that replacing primary 





Operational and system-related barriers to HPV self-sampling included fears about sample 
contamination, loss and identity theft, and women wanted to receive an acknowledgment 
that their kit had arrived at the laboratory safely. Although women’s preference for 
returning samples directly to healthcare providers rather than through the post has been 
identified in previous studies [36], this was the first study to highlight specific concerns 
about identity theft and perceived unwillingness of postal workers to handle samples. 
Confidence in the self-sampling programme was also influential because women wanted to 
understand the rationale for the set-up of a new cervical screening system, and expressed 
concerns that it might be motivated by political and financial reasons.  
 
The present study primarily investigated the attitudes of cervical screening attenders, many 
of whom had been identified as having a cervical abnormality previously and some of whom 
had received treatment for cervical abnormalities. By exploring the views of women who 
are engaged in the current screening programme, this research provided insight into the 
potential impact of modifying primary cervical screening on subsequent attendance. 
Ultimately, this research identified factors that might lead women currently engaged in 
cervical screening to drop out of cervical screening, should a new method be introduced.  
 
Study limitations are acknowledged. Individual survey items were combined to form scales 
based on the HBM constructs, with some exhibiting low internal reliability (Cronbach’s 
alpha). This may have been due to the breadth, such as the possible benefits associated with 
self-sampling or barriers associated with cervical screening, or the low number of items in 
the scale [45]. Consequent examination of mean inter-item correlations revealed 
correlations within the accepted range of 0.2 and 0.4 [45] and therefore we decided to 
combine the items into scales. Non-response bias is an issue commonly identified in postal 
surveys [46], and women who were cervical screening non-attenders, less educated and 
from an ethnic minority background were less likely to participate in this study. Only 137 
participants completed a questionnaire out of 11, 961 who were initially sent a recruitment 
leaflet. The low participation rate necessitated supplementary recruitment through 
community groups, GP practices and sexual health clinics to achieve sample size as well as 
to increase heterogeneity of the sample. The response rate of the supplementary 
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recruitment was unknown because it was not possible to record the number of individuals 
who were approached to participate and those who subsequently declined. However, 
although supplementary recruitment helped achieve sample size and representation of 
women from a broad age range, the majority of participants were white, highly educated, 
cervical screening responders. Furthermore, many of the participants had experienced 
cervical abnormalities, which might have influenced their perceptions of the utility of HPV 
self-sampling compared to cervical smear testing. The majority of women were recruited 
through Cervical Screening Wales and might have been more likely to take part in research 
because they were already engaged in the cervical screening process. The health beliefs of 
women who participate in research may be different to those of women who do not 
participate, and therefore may not represent population views. Further study limitations 
included the small sample size and opportunistic method of recruitment, which was 
reflected in the wide confidence interval observed for self-efficacy, and therefore limited 
generalisability of findings. The cross-sectional nature of the postal survey was useful for 
identifying the prevalence of hypothetical intention to self-sample within a given time [47], 
however it was unable to address cause and effect [48], and may have led to the 
observation of inflated associations between variables due to measurement at one point in 
time. In addition, hypothetical intentions to self-sample may not translate into actual uptake 
of a screening programme. However, the use of mixed methods enabled enrichment of the 
survey findings and the discovery of barriers not identified in the survey [49]. The type of 
information that is obtained from qualitative studies is rich in detail [50], and therefore 
necessitated a relatively small sample size so that the data could be analysed in depth. 
Interview participants were purposively recruited based on low intention to HPV self-sample 
as measured by the survey. Different themes might have been identified if women who had 
a higher intention to HPV self-sample had been recruited.  
The incorporation of HPV testing in the changing cervical screening programme within the 
UK presents an opportunity for future integration of primary HPV testing and the possibility 
of HPV self-sampling. Evidence presented in the current study suggests that personal 
barriers such as lack of knowledge and low self-efficacy in ability to self-sample correctly, as 
well as operational and system barriers such as concerns about reasons for establishing a 
new method for cervical screening, are influential in determining intention to engage in HPV 
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self-sampling. The insights gained can be used to guide further enquiry into the possibility of 
HPV self-sampling and inform future policy and practice. Should HPV self-sampling be 
incorporated into the cervical screening programme, psycho-educational interventions that 
increase HPV-related knowledge, perceived capability to HPV self-sample and confidence in 
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